Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Jeanneret Sozzi, Wendy ^a   Taghian, Alphonse ^b   Epelbaum, Ron ^c   Poortmans, Philip ^d   Zwahlen, Daniel ^e   Amsler, Beat ^f   Villette, Sylviane ^g   Belkacémi, Yazid ^g,h   Nguyen, Tan ⁱ   Scalliet, Pierre ^j   Maingon, Philippe ^k   Gutiérrez, Cristina ^l   Gastelblum, Pauline ^m   Krengli, Marco ⁿ   Raad, Rita ^b   Ozsahin, Mahmut ^a   Mirimanoff, René Olivier ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

^d DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g CENTRE OSCAR LAMBRET   (France)

^h HÔPITAL TENON   (France)

ⁱ INSTITUT JEAN GODINOT   (France)

^j CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^k CENTRE GEORGES FRANÇOIS LECLERC   (France)

^l CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^m JULES BORDET INSTITUTE   (Belgium)

ⁿ MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; METHOTREXATE; MITOXANTRONE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BREAST BIOPSY; BREAST LYMPHOMA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; UNIVARIATE ANALYSIS; BREAST TUMOR; CLINICAL TRIAL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RADIOTHERAPY; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 42649091182     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-86     Document Type: Article

References (37)

1. Freeman C Berg JW Cutler SJ Occurrence and prognosis of extranodal lymphomas Cancer 1972, 29:252-260 10.1002/ 1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-# 5007387
2. Mattia AR Ferry JA Harris NL Breast lymphoma: A B-cell spectrum including low-grade B-cell lymphoma of mucosa-associated lymphoid tissue Am J Surg Pathol 1993, 17:574-587 10.1097/00000478-199306000-00005 8333556
3. Arber DA Simpson JF Weiss LM Rappaport H Non-Hodgkin's lymphoma involving the breast Am J Surg Pathol 1994, 18:288-295 8116797
4. Topalovski M Cristan D Mattson JC Lymphoma of the breast: A clinicopathologic study of primary and secondary cases Arch Pathol Lab Med 1999, 123:1208-1218 10583925
5. Brogi E Harris NL Lymphomas of the breast: Pathology and clinical behavior Semin Oncol 1999, 26:357-364 10375092
6. Tanaka T Hsueh CL Hayashi K Awai M Nishihara K Konaga E Ishikawa J Orita K Primary malignant lymphoma of the breast: With a review of 3 cases among Japanese subjects Acta Pathol Jpn 1984, 34:361-373 6741549
7. Dixon JM Lumsden AB Krajewski A Elton RA Anderson TJ Primary lymphoma of the breast Br J Surg 1987, 74:214-217 10.1002/bjs.1800740322 3567516
8. Cohen PL Brooks JJ Lymphoma of the breast Cancer 1991, 67:1359-1369 10.1002/1097-0142(19910301)67:5<1359::AID-CNCR2820670515>3.0.CO;2-4 1991299
9. Giandini R Piccolo C Rilke F Primary non-Hodgkin's lymphoma of the female breast Cancer 1992, 69:725-735 10.1002/ 1097-0142(19920201)69:3<725::AID-CNCR2820690320>3.0.CO;2-C 1730123
10. Bobrow LG Richards MA Happerfield LC Diss TC Isaacson PG Lammie GA Millis RR Breast lymphomas: A clinicopathologic review Hum Pathol 1993, 24:274-278 10.1016/0046-8177(93)90037-H 8454272
11. Aviles A Delgade S Nambo J Neri N Murillo E Cleto S Primary breast lymphoma: Results of a controlled clinical trial Oncology 2005, 69:256-260 10.1159/000088333 16166814
12. Ryan G Martinelli G Kuper-Hommel M Tsang R Prumeri G Yuen K Roos D Lennard A Devizzi L Cragg S Hossfeld D Pratt G Dell'Olio M Choo SP Bociek RG Radford J Lade S Gianni AM Zucca E Cavalli F Seymour JF International Extranodal Lymphoma Study Group Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the International Extranodal Lyphoma Study Group Ann Oncol 2008, 19:233-41 10.1093/annonc/mdm471 17932394
13. Brustein S Filippa DA Kimmel M Lieberman PH Rosen PP Malignant lymphoma of the breast. A study of 53 patients Ann Surg 1987, 205:144-150 1492821 3545107 10.1097/00000658-198702000-00008
14. Domchek SM Hecht JL Fleming MD Pinkus GS Canellos GP Lymphomas of the breast: Primary and secondary involvement Cancer 2002, 94:6-13 10.1002/ cncr.10163 11815954
15. Kuper-Hommel MJJ Snijder S Jansen-Heijnen ML Vrints LW Kluin-Nelemans JC Coebergh JW Noordijk EM Vreugdenhil G Treatment and survival of 38 female breast lymphomas: A population-based study with clinical and pathological reviews Ann Hematol 2003, 82:397-404 10.1007/ s00277-003-0664-7 12764549
16. Ha CS Dubey P Goyal LK Hess M Cabanillas F Cox JD Localized primary non-Hodgkin's lymphoma of the breast Am J Clin Oncol 1998, 21:376-380 10.1097/00000421-199808000-00012 9708637
17. Wong WW Schild SE Halyard MY Schomberg PJ Primary non-Hodgkin's lymphoma of the breast: The Mayo Clinic experience J Surg Oncol 2002, 80(1):19-25 10.1002/jso.10084 11967901
18. Fruchart C Denoux Y Chasle J Peny AM Boute V Ollivier JM Genot JY Michels JJ High-grade primary breast lymphoma: Is it a different clinical entity? Breast Cancer Res Treat 2005, 93:191-198 10.1007/ s10549-005-5088-8 16172797
19. Ribrag V Bibeau F El Weshi A Freyfer J Fadd C Cebotaru C Laribi K Fenaux P Primary breast lymphoma: A report of 20 cases Br J Haematol 2001, 115:253-256 10.1046/j.1365-2141.2001.03047.x 11703318
20. Ganjoo K Advani R Mariappan MR McMillan A Horning S Non-Hodgkin's lymphoma of the breast Cancer 2007, 110:25-30 10.1002/cncr.22753 17541937
21. Rare Cancer Network http://www.rarecancer.net
22. Carbone PP Kaplan HS Mushoff K Smithers DW Tubiana M Report of the committee on Hodgkin's disease classification Cancer Res 1971, 31:1860-1861 5121694
23. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas Summary and description of Working Formulation for clinical usage Cancer 1982, 49:2112-2135 10.1002/ 1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2 6896167
24. Kaplan ES Meier P Non-parametric estimation from incomplete observations J Am Stat Assoc 1958, 53:457-481 10.2307/2281868
25. Peto R Pike MC Armitage P Breslow NE Cox DR Howard SV Mantel N McPherson K Peto J Smith PG Design and analysis of randomized clinical trials requiring prolonged observations of each patient. I. Introduction and design Br J Cancer 1976, 34:585-612 795448
26. Cox DR Regression models and life tables J Roy Stat Soc 1972, 34:187-220
27. Vignot S Ledoussal V Nodiot P Bourguingnat A Janvier M Mounier M Chérel P Floiras JL Turpin F Non-Hodgkin's lymphoma of the breast: A report of 19 cases and a review of the literature Clin Lymphoma 2005, 6:37-42 15989705
28. Lyons J Myles J Pohlman B Macklis RM Crowe J Crownover RL Treatment and prognosis of primary breast lymphoma: A review of 13 cases Am J Clin Oncol 2000, 23:334-336 10.1097/00000421-200008000-00003 10955857
29. DeBlasio D McCormick B Straus D Smith M Brustein S Nisce L Fuks Z Definitive irradiation for localized non-Hodgkin's lymphoma of the breast Int J Radiat Oncol Biol Phys 1989, 17:843-846 2777674
30. Dao AH Adkins RB Jr Glick AD Malignant lymphoma of the breast: A review of 13 cases Am Surg 1992, 58:792-796 1456611
31. Ariad S Lewis D Cohen R Bezwoda WR Breast lymphoma: A clinical and pathological review and 10-year treatment results S Afr Med J 1995, 85:85-89 7597540
32. Gholam D Bibeau F El Weshi A Bosq J Ribrag V Primary breast lymphoma Leuk Lymphoma 2003, 44:1173-1178 10.1080/1042819031000079195 12916870
33. Huang DZ He XH Yang S Shi YK Clinical and pathological analysis of 15 cases of primary breast lymphoma Ai Zheng 2004, 23:939-942 15301719
34. Yamazaki H Hanada M Kitada M Kuyama J Sato T Nishikubo M Ishida T Inoue T Inoue T Four cases of central nervous system involvement of breast malignant lymphoma Jpn J Clin Oncol 2003, 33:399-403 10.1093/jjco/hyg072 14523060
35. Habermann TM Weller EA Morrison VA Gascoyne RD Cassileth PA Cohn JB Dakhil SR Woda B Fisher RI Peterson BA Horning ST Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma J Clin Oncol 2006, 24:3121-3127 10.1200/ JCO.2005.05.1003 16754935
36. Hiddemann W Kneba M Dreyling M Schmitz N Lengfelder E Schmits R Reiser M Metzner B Harder H Hegewisch-Becker S Fischer T Kropff M Reis HE Freund M Wörmann B Fuchs R Planker M Schimke J Eimermacher H Trümper L Aldaoud A Parwaresch R Unterhalt M Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group Blood 2005, 106:3725-3732 10.1182/ blood-2005-01-0016 16123223
37. Avilés A Castañeda C Neri N Cleto S Nambo MJ Rituximab and dose-dense chemotherapy in primary breast lymphoma Haematologica 2007, 92:1147-48 10.3324/haematol.10892 17650450